XML 120 R96.htm IDEA: XBRL DOCUMENT v3.22.4
Schedule I - Balance Sheets (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Accounts receivable        
Other, net $ 6,684 $ 18,062    
Prepaid assets 84,759 48,042    
Other current assets 1,917 1,674    
Total current assets 367,829 340,003    
Other long-term assets:        
Investments in subsidiaries 1,745 0    
Total assets 3,058,626 2,766,815    
Current liabilities:        
Accounts payable 128,174 85,815    
Accrued liabilities 219,769 130,459    
Other current liabilities 60,359 33,061    
Total current liabilities 607,058 600,526    
Long-term liabilities:        
Other long-term liabilities 176,152 45,006    
Total liabilities 1,893,050 2,006,162    
Stockholdersʼ Equity:        
Preferred stock, $0.01 par value; 30,000,000 shares authorized and no shares issued or outstanding as of December 31, 2022 and 2021 0 0    
Common stock $0.01 par value; 270,000,000 shares authorized; 82,570,328 and 81,881,477 shares issued and outstanding as of December 31, 2022 and 2021, respectively 826 819    
Additional paid-in capital 1,699,799 1,676,798    
Accumulated deficit (535,049) (916,964)    
Total stockholdersʼ equity 1,165,576 760,653 $ 926,601 $ 1,078,277
Total liabilities and stockholdersʼ equity 3,058,626 2,766,815    
Parent        
Accounts receivable        
Other, net 0 523    
Prepaid assets 169 141    
Other current assets 36 0    
Total current assets 205 664    
Other long-term assets:        
Investments in subsidiaries 1,168,053 761,739    
Total assets 1,168,258 762,403    
Current liabilities:        
Accounts payable 249 178    
Accrued liabilities 728 497    
Other current liabilities 62 0    
Total current liabilities 1,039 675    
Long-term liabilities:        
Other long-term liabilities 1,643 1,075    
Total liabilities 2,682 1,750    
Stockholdersʼ Equity:        
Preferred stock, $0.01 par value; 30,000,000 shares authorized and no shares issued or outstanding as of December 31, 2022 and 2021 0 0    
Common stock $0.01 par value; 270,000,000 shares authorized; 82,570,328 and 81,881,477 shares issued and outstanding as of December 31, 2022 and 2021, respectively 826 819    
Additional paid-in capital 1,699,799 1,676,798    
Accumulated deficit (535,049) (916,964)    
Total stockholdersʼ equity 1,165,576 760,653    
Total liabilities and stockholdersʼ equity $ 1,168,258 $ 762,403